GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Discovery Laboratories, Inc. (DSCO) [hlAlert]

Rating:
Buy DSCO
down 83.85 %

Discovery Laboratories, Inc. (DSCO) rated Buy with price target $5 by Brean Murray

Posted on: Monday,  Feb 11, 2008  8:25 AM ET by Brean Murray

Brean Murray rated Buy Discovery Laboratories, Inc. (NASDAQ: DSCO) on 02/11/2008, when the stock price was $2.23. Since
then, Discovery Laboratories, Inc. has lost 83.86% as of 01/25/2016's recent price of $0.36.
If you would have followed this Brean Murray's recommendation on DSCO, you would have lost 83.85% of your investment in 2905 days.

Discovery Laboratories, Inc., formerly known as Ansan Pharmaceuticals, Inc., is a development-stage pharmaceutical company that focuses on developing compounds to treat respiratory diseases that affect the ability of the lungs to absorb oxygen. It is initially developing its lead product candidate, Surfaxin, for use by newborn infants to treat two respiratory conditions in critical care units of hospitals. The second compound under development is SuperVent, which is intended to treat airway diseases such as cystic fibrosis (CF) and chronic bronchitis.

Our equity research department is focused on fundamental analysis across the universe of over 200 small/mid cap stocks in our five target sectors. We are committed to providing proprietary action-oriented research to our institutional clients. Small cap growth focus. Our primary area of concentration is growth stocks with market capitalization of $200 million to $5 billion. Global perspective. We are covering U.S. listed stocks for companies domiciled in the U.S., China, Europe and Latin America, with our biggest concentration in the US and China. We were one of the first banks to aggressively expand our research to China and we believe we created one of the premier research franchises in small cap, U.S. listed Chinese companies to complement our strong domestic coverage. Disciplined stock selection. Our research analysts are focused on performing extensive bottoms up due diligence on companies under our coverage by leveraging their industry and management contacts. By combining our bottoms up work with our sector views we seek to generate a consistent flow of high conviction ideas for our clients. Diversified coverage. Our areas of expertise include technology, consumer, healthcare, resources and China small cap. We provide our clients with company-specific as well as sector-specific research across our target sectors.
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy